Fresenius SE
Home
|
Contacts
|
Imprint
|
Sitemap
|
Glossary
|
Guided Tour
|
German
WHO WE ARE
The Health Care Group
Products and Services
Facts and Figures
Locations Worldwide
Management Board
Supervisory Board
Environment
History
Frequently Asked Questions
Contacts
INVESTOR RELATIONS
The Fresenius Shares
Bonds and Rating
News
Financial Reports
Presentations
Corporate Governance
Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
PRESS
Press Releases
Photo Service
Audio/Video Service
TV Service
Calendar
Facts and Figures
Contacts
HEALTHCARE
Fresenius Medical Care
Dialysis at a Clinic or at Home
Hemodialysis
Peritoneal Dialysis
Supplemental Drugs
Other Extracorporeal Systems
Fresenius Kabi
Infusion Therapy
Clinical Nutrition
Home Care
Fresenius Helios
Care Structure
Medical Quality
Knowledge Management
HELIOS Highlights
Fresenius Vamed
Fresenius Biotech
Transplantation
Cancer Therapy
Cell and Gene Therapy
All Segments
CAREER
Why Fresenius?
Who we are looking for
Job Market
Online application
Career Fairs
Personnel in Numbers
Around our Plants
Contacts
SEARCH
The Fresenius Shares
Bonds and Rating
News
Investor News
2008
2007
2006
2005
2004
2003
Ad hoc News
Financial Reports
Presentations
Corporate Governance
Facts and Figures
Annual General Meeting
Financial Calendar and Conferences
Information & Order Service
Frequently Asked Questions
Contacts
Stock Dictionary
Fresenius Kabi to acquire APP Pharmaceuticals
Please click here for Press Releases, Investor News and additional information.
>>>
Share Price
Award for 2007 Annual Report
Fresenius was placed first in its category "Health Care - Equipment & Supplies" and granted once more the platinum award of the "2007 Vision Awards Annual Report Competition" of the League of American Communications Professionals (LACP), USA. More than 3,000 entries representing 21 countries were judged. Among all competitors, Fresenius SE was ranked 21th.
>>>
Next Event
2.12.2008
Capital Market Day
of Fresenius Helios
and Fresenius Vamed
in Berlin
>>>
Further events
>>>
Annual Report 2007
Please click here to view our Online-Annual Report 2007
>>>
To view PDF-files you need Adobe Reader. You can download this software free of charge.
Investor News 2003
04.11.2003
1st nine months 2003
(for tables please see pdf-file)
Text as PDF-File
23.09.2003
Phase I/II study completed successfully: New antibody to treat ovarian cancer patients with symptomatic ascites (fluid accumulation in the abdominal cavity) shown to be well tolerated
Text as PDF-File
05.08.2003
1st half 2003
(for tables please see pdf-file)
Text as PDF-File
07.05.2003
1st quarter 2003
(for tables please see pdf-file)
Text as PDF-File
07.03.2003
Fresenius announces change in chairmanship of Managing Board
25.02.2003
2002 Financial year
(for tables please see pdf-file)
Text as PDF-File
Home
>
Investor Relations
>
News
>
Investor News
>
2003